Skip to main content
. Author manuscript; available in PMC: 2013 Apr 1.
Published in final edited form as: Gynecol Oncol. 2011 Dec 22;125(1):70–74. doi: 10.1016/j.ygyno.2011.12.440

Table 1.

Participant characteristics and covariate information

Covariate S*=2 (1,545) S=3 (1,752) S=4 (3,375) S=5 (4,964) S=6 (16,402) Non-cancer (27,966) Cancer (72) All (28,038)
Age at baseline (years)
 Mean 63.40 63.27 64.15 63.45 61.44 62.34 63.74 62.35
 SD+ 5.48 5.34 5.02 5.16 5.24 5.33 5.63 5.33
Family history
 Yes (%) 65 (4.21) 65 (3.71) 119 (3.53) 192 (3.87) 655 (3.99) 1090 (3.90) 6 (8.33) 1096 (3.91)
 No (%) 1,480 (95.79) 1,687 (96.29) 3,256 (96.47) 4,772 (96.13) 15,747 (96.01) 26,876 (96.10) 66 (91.67) 26,942 (96.09)
Time interval between baseline and second to last test (months)
 Mean 7.28 19.84 29.34 40.97 49.40 41.38 21.83 41.33
 SD 12.51 11.51 8.06 5.41 1.78 13.37 15.90 13.41
CA-125 value at the second to last test
 Mean 13.10 12.77 12.77 12.33 11.96 12.23 17.14 12.24
 SD 15.34 8.36 11.74 9.39 11.06 10.99 15.61 11.01
Time interval between last two tests (months)
 Mean 15.12 14.97 14.43 18.45 11.84 13.70 12.31 13.70
 SD 10.73 8.54 6.61 6.55 2.12 5.72 3.59 5.72
Velocity (U/ml per month)
 Mean 0.50 0.33 0.19 0.03 0.02 0.04 19.75 0.09
 SD 10.78 4.52 7.23 0.90 0.90 1.27 68.76 3.82
*

S denotes the number of screening tests a woman took.

+

SD denotes the standard deviation.